Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ATAI LIFE SCIENCES N.V.

(ATAI)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Atai Life Sciences Boosts Stake in Compass Pathways

11/29/2021 | 08:34am EST


ę MT Newswires 2021
All news about ATAI LIFE SCIENCES N.V.
10:36aAtai Launches Platform Company Invyxis, Partners With Dalriada to Develop Mental Health..
MT
06:59aAtai Life Sciences Launches Invyxis to Accelerate Discovery of Next-Generation Mental H..
AQ
01/12ATAI LIFE SCIENCES : FDA Grants Investigational New Drug to PCN-101 R-ketamine Program
DJ
01/12Atai Life Sciences Receives FDA Clearance to Conduct Anti-Depressant Study
MT
01/12Atai Life Sciences announces FDA Investigational New Drug (IND) Clearance for PCN-101 R..
AQ
01/12Atai Life Sciences Announces Fda Investigational New Drug Clearance for Pcn-101 R-Ketam..
CI
01/06RBC Cuts Price Target on Atai Life Sciences to $12 From $17, Maintains Sector Perform R..
MT
2021European ADRs Move Lower in Monday Trading
MT
2021ATAI LIFE SCIENCES N.V.(NASDAQGM : ATAI) added to S&P Global BMI Index
CI
2021ATAI LIFE SCIENCES N.V.(NASDAQGM : ATAI) added to NASDAQ Biotechnology Index
CI
More news
Analyst Recommendations on ATAI LIFE SCIENCES N.V.
More recommendations
Financials (USD)
Sales 2021 17,2 M - -
Net income 2021 -116 M - -
Net cash 2021 385 M - -
P/E ratio 2021 -5,68x
Yield 2021 -
Capitalization 747 M 747 M -
EV / Sales 2021 21,0x
EV / Sales 2022 7 650x
Nbr of Employees 35
Free-Float 90,8%
Chart ATAI LIFE SCIENCES N.V.
Duration : Period :
Atai Life Sciences N.V. Technical Analysis Chart | ATAI | NL0015000DX5 | MarketScreener
Technical analysis trends ATAI LIFE SCIENCES N.V.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 14
Last Close Price 4,66 $
Average target price 28,54 $
Spread / Average Target 512%
EPS Revisions
Managers and Directors
Florian Brand Chief Executive Officer
Gregory L. Weaver Chief Financial Officer
Srinivas G. Rao Chief Scientific Officer
Rolando GutÝerrez-Esteinou Chief Medical Officer
Alexis Marc Joel Louis de Rosnay Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
ATAI LIFE SCIENCES N.V.-38.93%782
MODERNA, INC.-38.99%62 828
LONZA GROUP AG-20.54%48 784
IQVIA HOLDINGS INC.-17.54%44 443
SEAGEN INC.-20.08%22 592
ICON PUBLIC LIMITED COMPANY-18.28%20 601